KN-17

• UNSPSC Description:

  KN-17 is a modified based on the structure of cecropin B (HY-P0092), can effectively interfere with bacterial growth and induce the migration of human bone marrow stromal cells (hBMSCs). KN-17 can significantly stimulate angiogenesis in vitro and in vivo[1].

• Target Antigen:

  Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/kn-17.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC3=CC=C(O)C=C3)C(O)=O)=O)=O)=O)=O)C4=CC=C5C(C=CC(OC)=C5)=C4

• Molecular Weight:

  816.89

• References & Citations:

  [1]Zhao B, et al. Peptide KN-17-Loaded Supramolecular Hydrogel Induces the Regeneration of the Pulp-Dentin Complex. ACS Biomater Sci Eng. 2024 Mar 6.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported